ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

Study: Negative HPV Test More Accurate than Negative Pap Test In Predicting Cervical Cancer Risk

July 25, 2014

Roswell Park Prepares for Sequestration

February 22, 2013